Paratek Pharmaceuticals, Inc. (PRTK) Financials

NASDAQ Currency in USD Disclaimer

$2.23

north_east NA Past Year
Day's range
$2.19
Day's range
$2.24
$200M$200M$150M$150M$100M$100M$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning201620162017201720182018201920192020202020212021202220220%0%-100000%-100000%-200000%-200000%-300000%-300000%-400000%-400000%-500000%-500000%-600000%-600000%-700000%-700000%Profit Margin
Profit Margin
Revenue
Earnings

PRTK Income statement / Annual

Last year (2022), Paratek Pharmaceuticals, Inc.'s total revenue was $150.79 M, an increase of 24.67% from the previous year. In 2022, Paratek Pharmaceuticals, Inc.'s net income was -$63.57 M. See Paratek Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $150.79 M $120.95 M $43.52 M $16.54 M $17.12 M $12.62 M $29,000.00 $0.00 $4.34 M $1.75 M
Cost of Revenue $23.06 M $21.54 M $8.65 M $3.48 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $127.73 M $99.42 M $34.87 M $13.06 M $17.12 M $12.62 M $29,000.00 $0.00 $4.34 M $1.75 M
Gross Profit Ratio 0.85 0.82 0.8 0.79 1 1 1 0 1 1
Research and Development Expenses $37.82 M $30.35 M $23.92 M $39.55 M $57.51 M $60.07 M $83.46 M $50.77 M $5.01 M $6.90 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $63.66 M $36.97 M $26.40 M $19.99 M $5.85 M $12.43 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.82 M
Selling, General & Administrative Expenses $145.60 M $119.40 M $89.86 M $89.14 M $63.66 M $36.97 M $26.40 M $19.99 M $5.85 M $19.25 M
Other Expenses -$9.48 M -$9.21 M -$3.41 M -$31,000.00 -$44,000.00 -$34,000.00 $4,000.00 -$37,000.00 -$299,000.00 $2.96 M
Operating Expenses $173.94 M $140.55 M $110.37 M $128.69 M $121.17 M $97.04 M $109.86 M $70.75 M $10.86 M $26.16 M
Cost And Expenses $197.00 M $162.08 M $119.02 M $132.17 M $121.17 M $97.04 M $109.86 M $70.75 M $10.86 M $26.16 M
Interest Income $752,000.00 $66,000.00 $1.52 M $3.57 M $3.26 M $1.38 M $1.07 M $0.00 $0.00 $0.00
Interest Expense $18.12 M $17.41 M $20.24 M $16.40 M $10.99 M $5.08 M $3.22 M $770,000.00 $718,000.00 $0.00
Depreciation & Amortization $1.31 M $445,000.00 $1.57 M $3.54 M -$1.07 M $1.27 M $2.30 M $714,000.00 $196,000.00 $90,000.00
EBITDA -$44.90 M -$40.69 M -$73.93 M -$112.09 M -$100.83 M -$83.08 M -$106.46 M -$70.79 M -$6.62 M -$21.45 M
EBITDA Ratio -0.3 -0.34 -1.7 -6.78 -5.89 -6.59 -3670.86 0 -1.53 -12.28
Operating Income Ratio -0.31 -0.34 -1.74 -6.99 -6.08 -6.7 -3775.38 0 -1.8 -15.67
Total Other Income/Expenses Net -$17.30 M -$17.35 M -$21.04 M -$12.86 M -$7.77 M -$3.74 M -$2.15 M -$807,000.00 -$10.04 M -$75,000.00
Income Before Tax -$63.51 M -$58.48 M -$96.54 M -$128.49 M -$111.85 M -$88.32 M -$111.64 M -$70.86 M -$17.84 M -$27.45 M
Income Before Tax Ratio -0.42 -0.48 -2.22 -7.77 -6.53 -7 -3849.52 0 -4.11 -15.71
Income Tax Expense $57,000.00 $600,000.00 $19.72 M $301,000.00 $502,000.00 $753,000.00 $3.23 M $19,000.00 $419,000.00 $2.95 M
Net Income -$63.57 M -$59.08 M -$116.26 M -$128.79 M -$112.36 M -$89.07 M -$111.64 M -$70.86 M -$17.84 M -$27.45 M
Net Income Ratio -0.42 -0.49 -2.67 -7.78 -6.56 -7.06 -3849.52 0 -4.11 -15.71
EPS -1.17 -1.22 -2.63 -3.93 -3.57 -3.32 -5.51 -4.29 -7.05 -17.54
EPS Diluted -1.17 -1.22 -2.63 -3.93 -3.57 -3.32 -5.51 -4.29 -7.05 -17.54
Weighted Average Shares Out $54.39 M $48.42 M $44.17 M $32.79 M $31.51 M $26.83 M $20.25 M $16.50 M $2.53 M $1.56 M
Weighted Average Shares Out Diluted $54.39 M $48.42 M $44.17 M $32.79 M $31.51 M $26.83 M $20.25 M $16.50 M $2.53 M $1.56 M
Link